News zum Sektor Gesundheit aus China

Es sind 101 ETFs & Fonds zum Sektor Gesundheit bekannt.

Es sind 1559 Aktien zum Sektor Gesundheit bekannt.

>Gesundheit News China
- Top- News
- Alle News
- Branchenanalysen
- Aktienanalysen
- News zum Land A..
  - Afghanistan
  - Afrika
  - Albanien
  - Algerien
  - Angola
  - Argentinien
  - Armenien
  - Aserbaidschan
  - Asien
  - Australien
  - Australien & Ozeanien
- News zum Land B..
  - Bahamas
  - Bahrain
  - Bangladesch
  - Barbados
  - Belarus
  - Belgien
  - Belize
  - Benin
  - Bermuda
  - Bhutan
  - Bolivien
  - Bosnien und Herzegowina
  - Botswana
  - Brasilien
  - Britische Jungferninseln
  - Brunei
  - Bulgarien
  - Burkina Faso
  - Burundi
- News zum Land C..
  - Chile
  - China
  - Costa Rica
- News zum Land D..
  - Deutschland
  - Dominikanische Republik
  - Dschibuti
  - Dänemark
- News zum Land E..
  - Ecuador
  - El Salvador
  - Elfenbeinküste
  - Eritrea
  - Estland
  - Europa
- News zum Land F..
  - Fidschi
  - Finnland
  - Frankreich
- News zum Land G..
  - Gabun
  - Gambia
  - Georgien
  - Ghana
  - Griechenland
  - Großbritannien
  - Grönland
  - Guatemala
  - Guinea
  - Guyana
- News zum Land H..
  - Haiti
  - Honduras
  - Hong Kong (China)
- News zum Land I..
  - Indien
  - Indonesien
  - Irak
  - Iran
  - Irland
  - Island
  - Israel
  - Italien
- News zum Land J..
  - Jamaika
  - Japan
  - Jemen
  - Jordanien
- News zum Land K..
  - Kaimaninseln
  - Kambodscha
  - Kamerun
  - Kanada
  - Kasachstan
  - Katar
  - Kenia
  - Kirgisistan
  - Kolumbien
  - Kongo
  - Kosovo
  - Kroatien
  - Kuba
  - Kuwait
- News zum Land L..
  - Laos
  - Lateinamerika
  - Lesotho
  - Lettland
  - Libanon
  - Liberia
  - Libyen
  - Liechtenstein
  - Litauen
  - Luxemburg
- News zum Land M..
  - Madagaskar
  - Malawi
  - Malaysia
  - Mali
  - Marokko
  - Mauretanien
  - Mauritius
  - Mexiko
  - Moldau
  - Mongolei
  - Montenegro
  - Mosambik
  - Myanmar
- News zum Land N..
  - Naher Osten
  - Namibia
  - Nepal
  - Neuseeland
  - Nicaragua
  - Niederlande
  - Niger
  - Nigeria
  - Nordamerika
  - Nordkorea
  - Nordmazedonien
  - Norwegen
- News zum Land O..
  - Oman
  - Ostblock
  - Osttimor
- News zum Land P..
  - Pakistan
  - Palästina
  - Panama
  - Papua-Neuguinea
  - Paraguay
  - Peru
  - Philippinen
  - Polen
  - Portugal
- News zum Land R..
  - Ruanda
  - Rumänien
  - Russland
- News zum Land S..
  - Sambia
  - Saudi-Arabien
  - Schweden
  - Schweiz
  - Senegal
  - Serbien
  - Sierra Leone
  - Simbabwe
  - Singapur
  - Slowakei
  - Slowenien
  - Somalia
  - Spanien
  - Sri Lanka
  - Sudan
  - Syrien
  - Südafrika
  - Südkorea
- News zum Land T..
  - Tadschikistan
  - Taiwan (China)
  - Tansania
  - Thailand
  - Togo
  - Tschad
  - Tschechien
  - Tunesien
  - Turkmenistan
  - Türkei
- News zum Land U..
  - Uganda
  - Ukraine
  - Ungarn
  - Uruguay
  - USA
  - Usbekistan
- News zum Land V..
  - Venezuela
  - Vereinigte Arabische Emirate
  - Vietnam
- News zum Land Z..
  - Zentralafrikanische Republik
  - Zypern
- News zum Land Ä..
  - Ägypten
  - Äthiopien
- News zum Land Ö..
  - Österreich

14.07.26 - 04:30	Alert: PHARMARON Expects Interim Net Profit to Rise Up to 10% YoY (AAStocks)
	PHARMARON (03759.HK) issued a positive profit alert, expecting interim revenue for the period ended end-Jun this year to reach approximately RMB7.472 billion to RMB7.665 billion, up 16% to 19% YoY. Net profit is expected to be approximately RMB729 million to RMB772 million, up 4% to 10% YoY. Net profit after deducting non-recurr......

13.07.26 - 14:24	Here are Mondays biggest analyst calls: Nvidia, SpaceX, Tesla, Apple, Netflix, Deckers, Biogen, Nio & more (CNBC)
	Here are Monday's biggest calls on Wall Street....

13.07.26 - 11:01	Leads Biolabs Announces Multiple Studies Selected for ESMO 2026, Highlighting the Growing Global Competitiveness of Its Core Pipeline (PR Newswire)
	NANJING, China, July 13, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that six of its latest research studies have been accepted for presentation at the 2026 European Society for Medical Oncology (ESMO) Annual......

13.07.26 - 11:00	ZHAOKE OPHTH-B Acquires Global Rights to Atropine Sulfate Eye Drops (AAStocks)
	ZHAOKE OPHTH-B (06622.HK) announced that on 22 June, the company acquired the global rights to NVK002 (atropine sulfate eye drops), a drug intended to slow the progression of myopia in children. Under the terms of the agreement, the company will obtain global ownership of all intellectual property, trademarks, regulatory filings......

13.07.26 - 06:30	ANTENGENE-B Receives USD60 million Upfront Payment from UCB (AAStocks)
	ANTENGENE-B (06996.HK) announced that, under the global exclusive licensing agreement reached with UCB for the CD19/CD3 bispecific T-cell engager (TCE) antibody ATG-201, it has received the first upfront payment of USD60 million from the company. The company expects the payment to further strengthen the group's cash position, pr......

13.07.26 - 06:03	Antengene Announces Receipt of USD 60 Million Upfront Payment from UCB (PR Newswire)
	SHANGHAI and HONG KONG, July 13, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for......

13.07.26 - 04:45	INSILICO Jumps Up 5% after Nailing CNS Drug R&D Partnership with CMS (AAStocks)
	Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...

13.07.26 - 04:45	HANSOH PHARMA HS-20093 Meets Primary Endpoint in Phase III Trial for Small Cell Lung Cancer (AAStocks)
	Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...

13.07.26 - 04:45	HENGRUI PHARMA Ioversol Injection Newly Included in National Essential Medicines List (AAStocks)
	Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...

13.07.26 - 02:33	Deepening Collaboration in AI-Powered R&D Acceleration: Insilico Medicine and CMS announce additional collaborations in CNS diseases (PR Newswire)
	SHANGHAI, July 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), and China Medical System Holdings Limited ("CMS", 867.HK/8A8.SG), an open-platform innovative company linking......

12.07.26 - 22:00	What This MeiraGTx Insider Sale Might Mean With Two Drug Filings Near (Fool)
	Stuart Naylor's 4% portfolio reduction follows an 89% one-year stock surge, executed under a pre-scheduled Rule 10b5-1 trading plan adopted in December 2025....

12.07.26 - 18:46	China investiert neuerdings massiv in den Bereich Biotechnologie (Tagesschau)
	China hat die Biotechnologie als Schlüsselbranche entdeckt. Der globale Konkurrenzdruck wächst. Es wäre nicht der erste Industriebereich, in dem China den Westen abhängt. Von Marie von Mallinckrodt....

10.07.26 - 18:30	ClearBridge International Growth Strategy: Adds ABB, BUD; exits SAP, Wuxi AppTec in Q2 (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

10.07.26 - 15:12	Hansoh Pharma: Phase III Trial For Ris-Rez Meets Primary Endpoint In China (AFX)
	BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - GSK plc (GSK, GSK.L) licensor Hansoh Pharmaceutical Group announced that ARTEMIS-008, its phase III trial evaluating risvutatug rezetecan or Ris-Rez in patient......

10.07.26 - 14:12	GSK Says Lung Cancer Drug Helps Patients in China Live Longer (Bloomberg)
	An experimental drug GSK Plc is developing with Hansoh Pharmaceutical Group helped patients with small-cell lung cancer live for longer in a late-stage Chinese trial....

10.07.26 - 13:33	GSK partner Hansoh posts late-stage trial win for lung cancer drug in China (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

10.07.26 - 11:00	HENLIUS IND Application for Phase 1 Clinical Trial of HLX37 Combined With HLX43 for Solid Tumor Treatment Approved by NMPA (AAStocks)
	HENLIUS (02696.HK) announced that the investigational new drug (IND) application for a Phase 1 clinical trial of the company's self-developed HLX37 (recombinant humanized bispecific antibody injection targeting PD-L1 and VEGF) combined with chemotherapy or HLX43 for injection (antibody-drug conjugate targeting PD-L1) for the tre......

10.07.26 - 10:57	Priority Review Granted to PD-L1/4-1BB Bispecific Antibody Opamtistomig, Accelerating Commercialization and Addressing Unmet Need in EP-NEC (PR Newswire)
	NANJING, China, July 10, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that the biologics license application (BLA) for Opamtistomig (LBL-024, a PD-L1/4-1BB bispecific antibody) as monotherapy for the treatment......

10.07.26 - 08:00	Research: Nomura Sees Asian Companies Seizing Global GLP-1 Receptor Agonist Opportunities, Raises TPs for WUXI APPTEC and INNOVENT BIO (AAStocks)
	Nomura published a report stating that growth in the market for GLP-1 receptor agonists (GLP-1 RAs) in the rest of the world (ROW) will drive significant expansion of the drug category. The global GLP-1 RAs market is currently valued at USD72 billion. According to third-party forecasts, the market size is expected to reach USD18......

10.07.26 - 07:15	IMMUNEONCO-B IMM0306 Completes First Patient Dosing in Phase II/III Trial for IgG4-Related Disease (AAStocks)
	IMMUNEONCO-B (01541.HK) announced that the Phase II/III trial of IMM0306 for the treatment of IgG4-related disease (IgG4-RD) has successfully completed first patient dosing. IgG4-RD is a chronic, progressive fibroinflammatory disease that may affect multiple organ systems, including the pancreas, bile ducts, salivary glands, lac......

>weitere News anzeigen...